A maintenance dose may be lower than the dose used during active weight loss, but it can also be the same dose or even a relatively high one
Clinical Evidence: What Studies Show About Liquid GLP-1 Delivery Most peer-reviewed trials on GLP-1 effectiveness used injectable formulationssemaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)which produced consistent, reproducible weight loss
Description Additional information Description AOD9604 Peptide Liquid Spray **Important Information: Each peptide comes lyophilized/freeze-dried and must be reconstituted with Bacteriostatic Water in order to be dispensable in liquid form
This reduces the appearance of fine lines, improves skin firmness, and protects skin from environmental ageing factors
Research in humans is a bit less impressive Clinical trials in humans A 1981 double-blind study found that chronic insomniac patients found that subjects slept 59% more, shorter sleep latency, and higher sleep efficiency (Schneider 1981) A 1987 double-blind study did not find any statistically significant changes in sleep structure as measured by REM sleep, NREM sleep, or total sleep time (Debellis 1987) A 1992 double-blind study in 14 chronic insomnia patients found higher sleep efficiency and subjectively estimated tiredness decreased to similar levels of healthy subjects in 7 nights of injections (Schneider 1992) There are some limitations to these studies however
